The invention disclosed herein is a stable topical liquid crystalline gel formulation comprising Adapalene, Clindamycin and Niacinamide along with pharmaceutical acceptable excipients, useful in the treatment of acne vulgaris.
The invention disclosed herein is a topical pharmaceutical composition comprising Ubidecarenone or Coenzyme Q 10, Diosmin, Magnesium sulphate, Methyl salicylate, and at least one penetration enhancer along with one or more pharmaceutically acceptable excipients, useful for improving blood circulation, for preventing...
Disclosed herein is a bilayer pharmaceutical tablet composition comprising Levocetirizine and Ranitidine along with pharmaceutically acceptable excipients, useful in the treatment of allergic conditions and urticarial. The invention further discloses the process for preparation of the bilayer tablet.
...
The invention disclosed herein is a novel liquid pharmaceutical composition comprising a combination of Sucralfate, a gastrointestinal medication and Domperidone a peripheral dopamine receptor antagonist; along with pharmaceutically acceptable exicipients useful for the treatment of gastroesophageal reflux disease (...
The present invention relates to a stable liquid composition comprising therapeutically effective quantities of alkali metal citrates, more specifically K-citrate and Mg-citrate in combination with Vitamin B6 compound, specifically pyridoxine and pharmaceutically acceptable excipients. The present invention further ...
Pharmaceutical composition comprising of ubidecarenone (coenzyme Q10) and HMO CoA reductase inhibitor preferably atorvastatin formulated as film coated tablet dosage form useful for the treatment of elevated blood lipid level-related diseases and conditions
associated with coenzyme Q10 deficiency and process for p...
The invention discloses stable topical pharmaceutical composition comprising Mupirocin and collagen (bioactive polymer). More preferably, the invention discloses pharmaceutical composition of Mupirocin and bioactive polymer as wound healing synergiser in ointment formulation and further discloses its method of manuf...
Disclosed herein is pharmaceutical compositions of Probiotics and Melatonin for oral administration useful in the treatment of Irritable bowel syndrome (IBS).